Tokyo, June 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061993) titled 'A Prospective Study Evaluating the Clinical Utility of Comprehensive Genomic Testing Before Completion of Standard Treatment in Patients With Advanced or Recurrent Cancer' on June 22.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Okayama University
Condition:
Condition - Patients with advanced or recurrent solid tumors who are candidates for systemic therapy and are not eligible to undergo comprehensive genomic profiling (CGP) testing under the national insurance system before...